1-[2-Amino-1-[1-(naphthyloxy)methyl] ethyl] piperidine hydrochloride: specific inhibition of brain serotonin uptake and related activities.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000577:Amides / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002395:Catecholamines / Q000378:metabolism; D002540:Cerebral Cortex / Q000648:ultrastructure; D004347:Drug Interactions; D005277:Fenfluramine / Q000494:pharmacology; D066298:In Vitro Techniques; D007980:Levodopa / Q000494:pharmacology; D008297:Male; D051379:Mice; D009206:Myocardium / Q000378:metabolism; D010095:Oxotremorine / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000378:metabolism*; D013574:Synaptosomes / Q000378:metabolism; D010133:p-Chloroamphetamine / Q000494:pharmacology
D000577:Amides; D002395:Catecholamines; D010880:Piperidines; D005277:Fenfluramine; D012701:Serotonin; D007980:Levodopa; D010095:Oxotremorine; D010133:p-Chloroamphetamine; D006916:5-Hydroxytryptophan